Latest 1

European community FP7

(24.01.2014)
Genekam Biotechnology AG has been selected for business mission trip to Tokyo, 26-30 May 2014 under EU GATEWAY TO JAPAN-Healthcare and Medical technologies. Genekam Biotechnology AG is one of 40 companies selected across the European Union.

(13.06.2012)
Genekam got one project for development of Nanoassays for nanomedicine under program ZIM
GENEKAM Biotechnology AG from German Federal Ministry of Economics and Technology.

(02.01.2012)
Genekam is to take part in European Community FP7 ... read more...

Latest 2

ArabLab The Expo 2014

Visit us in Dubai, UAE from 17.03 to 20.03.2014
arablab.com

26. CHINA MED 2014

Visit us in Beijing / VR China 21.03. - 23.03.2014
chinamed.net.cn

Medica Düsseldorf 2014

Visit us on Medica 2014 in Düsseldorf from 12.11 to 15.11.2014
medica.de

Latest 3

New Catalog 2014

Our new Catalog is now released, please download klick here

Latest 4

Hard fact - is it a sign of quality and confidence in our product?

... in 2004 we had clients in 5 countries in whole year and in 2009 we served 60 countries of the world? There is a surge of medical publications where Genekam PCR Kits are being used. Is it not a sign of quality and trust ?
read more...

Latest 5

Real time PCR Kits for Influenza A and swine flu (H1N1) (click here to see more information) read more...

Latest 6

In vitro immunisation of human b-lymphocytes and human monoclonal antibodies read more...

Latest 7

Genekam Solutions for combating SARS viruses read more...

Latest 8

Genekam 3D-Stemcell-Solutions read more...

Latest 9

Genekam 解决方案对抗SARS病毒 read more...

Latest 10

Genekam-Barcode: Biotech for nature and endangered species
(A new DNA-Test to know the exact species of an animal) read more...

Technical details for realtime PCR kit Human hepatitis B virus



FR007 Human hepatitis B virus, 100 reactions

Human Hepatitis B Virus (HBV) is one of the most frequently parenterally transmitted viruses and needs special diagnostic assays as well as safety steps for blood and blood products. Quantitive assays should cover wide range of concentrations since the absolute viral load as well as its time course are important diagnostic parameters for indicating the prognosis as well as therapy. HBV can be detected through cell culture methods as well as serological methods like ELISA etc, but these all methods have one or other following drawbacks: low sensitivity, cross reactions or need a long time for detection, therefore PCR is merging as godstandard as this is highly sensitive and finished within a few hours. With real time PCR, one can get the results within 3-4 hours as there is no post PCR stage. In case one can run the known standards with PCR, it can give you the exact number of copies present in the sample. In case the quantititive standard is not available, one can compare 2 samples as one see the HBV load as curve during real time assay. Real time curves can be helpful during the antiviral therapy and predict the success of the treatment.
In case the viral load is going down, it means that the therapy is going to be successful, otherwise one has to think about other alternatives.

target gene: highly conserved region of HBV gene

Samples: blood, serum, plasma, cell culture, tissue and other body fluids. This needs isolated DNA, which can be isolated through commercial DNA isolation kit.

Keypoints : It has been checked for cross reactions for related and non related micro organisms.

Detection limit: minimum : 100 genome equivalent per assay (detection Ct is lower 36 (this should be taken as positive); 36-40 Ct should be taken as weak positive.)

Contents of the kit: Polymerase, buffer, PCR master mix, nucleotides, primers, probes (with 6-carboxyfluoresceine and 6-carboxytetramethylrhodamine), positive control, negative control, molecular water and manual.

Storage: -20 degree

Recommendations: always run the two samples per probe.

- only for in vitro use
- only for research use
- to be used through technical person.



manual

Last modified:
2012-04-05 12:46:27